Acasti Pharma, Inc. - (ACST) Social Stream
ACASTI PHARMA INC (ACST) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ACST.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued June 22, 2022
The Trend in the Analyst Price Target
Over the past 26 months, ACST's average price target has gone up $2.08.
Over the past 26 weeks, ACST's average upside potential has been 333.53%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ACST Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 24 months, ACST's average broker recommendation rating improved by 0.4.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ACST as an investment opportunity.
- In the context of all US stocks, ACASTI PHARMA INC's number of analysts covering the stock is higher than practically none of them.
- In the context of all US stocks, ACASTI PHARMA INC's variance in analysts' estimates is lower than almost 100% of them.
- In terms of how ACASTI PHARMA INC fares relative to Healthcare stocks, note that its average analyst price target is greater than 15.25% of that group.
- In the context of Healthcare stocks, ACASTI PHARMA INC's upside potential (average analyst target price relative to current price) is greater than 173.22% of them.
What is the outlook for ACST? Use POWR Ratings for clearer insight into price direction.